coronavirus
famili
coronavirida
larg
envelop
rna
virus
respons
highli
preval
diseas
human
be
domest
anim
canin
coronavirus
ccov
caus
mild
moder
enter
dog
young
pup
viru
occur
concurr
pathogen
diarrhoea
may
sever
dehydr
loss
appetit
even
death
appel
infect
dog
gener
shed
ccov
faec
six
nine
day
infect
keenan
other
although
viru
detect
faec
six
month
clinic
sign
ceas
pratelli
other
pratelli
ccov
highli
contagi
viru
establish
kennel
spread
infect
difficult
control
crowd
unsanitari
condit
stress
train
environment
condit
appear
favour
develop
clinic
diseas
evermann
other
yasoshima
other
pratelli
other
decaro
other
disinfect
kennel
equip
per
cent
hypochlorit
solut
effect
kill
ccov
prevent
transmiss
efficaci
durat
immun
provid
ccov
vaccin
controversi
carmichael
recent
studi
describ
low
efficaci
inactiv
ccov
vaccin
reduc
viral
shed
faec
dog
challeng
pratelli
other
safeti
immunogen
experiment
ccov
vaccin
administ
intramuscularli
oronas
subsequ
shown
pratelli
other
studi
pcr
show
excret
vaccin
viru
faec
oronas
inocul
present
studi
report
result
vaccin
trial
ccov
vaccin
administ
via
oronas
rout
seven
stray
dog
four
femal
three
male
includ
present
studi
dog
test
neg
pcr
ccov
antigen
faec
ccov
antibodi
sera
baselin
bodi
temperatur
white
blood
cell
wbc
count
determin
dog
calcul
averag
measur
taken
three
day
vaccin
experiment
studi
perform
accord
anim
health
wellb
regul
authoris
italian
ministri
health
authoris
number
complet
studi
dog
adopt
privat
individu
except
one
remain
studi
kennel
polici
kennel
local
ordin
requir
dog
human
care
ccov
vaccin
strain
strain
use
origin
isol
dog
mild
enter
pratelli
other
viru
passag
canin
cell
subsequ
passag
addit
time
new
vaccin
stock
infect
titr
tissu
cultur
infecti
dose
tcid
test
use
standardis
method
aerob
anaerob
bacteria
mycoplasma
mycet
contamin
virus
neg
viral
suspens
sterilis
passag
filter
millex
millipor
corpor
cell
cultur
infect
hour
test
pestivir
use
immunofluoresc
test
monoclon
antibodi
evalu
presenc
mould
yeast
vaccin
stock
cultur
onto
sabouraud
dextros
agar
gl
chloramphenicol
biolif
italiana
srl
incub
seven
day
day
safeti
vaccin
evalu
two
dog
given
oronas
inocul
vaccin
dose
time
greater
use
efficaci
test
two
control
dog
given
ml
intranas
rout
plu
ml
oral
follow
inocul
dog
hous
individu
examin
daili
day
sign
ill
includ
wbc
count
bodi
temperatur
individu
faecal
sampl
collect
virolog
assay
carri
three
day
test
day
day
blood
taken
dog
serolog
test
acclimatis
period
day
three
dog
kept
isol
separ
room
handl
separ
oper
dog
vaccin
oronas
rout
ml
ml
nasal
rout
ml
oral
rout
day
later
dog
receiv
second
oronas
dose
vaccin
two
dog
hous
separ
vaccin
control
group
first
second
vaccin
dog
observ
watch
advers
local
system
reaction
faecal
sampl
collect
daili
day
vaccin
dpfv
day
vaccin
dpsv
fourteen
day
second
dose
vaccin
control
dog
challeng
ccov
field
strain
strain
isol
diarrhoeic
pup
marsilio
other
viru
propag
primari
canin
embryon
kidney
cell
cultur
three
passag
store
challeng
dog
receiv
ml
viral
suspens
ml
intranas
ml
oral
titr
day
challeng
day
dpc
vaccin
control
dog
examin
sign
ill
viru
shed
monitor
daili
ccov
usual
caus
clinic
diseas
experiment
challeng
suscept
dog
challeng
studi
monitor
evalu
median
day
viral
shed
blood
sampl
collect
three
vaccin
dog
vaccin
seven
dpfv
seven
dpsv
addit
sampl
collect
vaccin
control
dog
seven
dpc
test
antibodi
respons
monitor
seroconvers
faecal
sampl
collect
vaccin
control
dog
test
viru
isol
pcr
assay
attempt
viru
isol
sampl
homogenis
per
cent
weightvolum
minim
essenti
medium
treat
antibiot
iuml
penicillin
streptomycin
amphotericin
b
inocul
duplic
onto
freshli
trypsinis
cell
plate
contain
glass
slide
monolay
observ
daili
cytopath
effect
hour
cell
fix
cold
aceton
examin
immunofluoresc
test
use
coronaviru
monoclon
antibodi
sampl
consid
neg
cytopath
effect
immunofluoresc
occur
three
serial
passag
pcr
assay
perform
previous
report
pratelli
other
viral
rna
extract
clinic
specimen
use
rneasi
kit
qiagen
target
sequenc
fragment
gene
encod
membran
protein
ccov
amplifi
base
pair
fragment
revers
transcript
perform
total
reaction
volum
contain
pcr
buffer
kcl
ph
deoxynucleotid
datp
dctp
dgtp
dttp
u
rnase
inhibitor
u
murin
leukaemia
viru
revers
transcriptas
u
random
hexam
synthesi
complementari
dna
carri
minut
follow
denatur
step
five
minut
mixtur
brought
total
volum
contain
pcr
buffer
u
amplitaq
gold
dna
polymeras
perkin
elmer
cetu
pmol
primer
amplif
perform
follow
pcr
condit
cycl
denatur
one
minut
anneal
one
minut
extens
one
minut
neg
posit
sampl
faec
specif
dog
ccov
strain
respect
use
pcr
control
final
product
detect
gel
electrophoresi
ethidium
bromid
stain
uv
light
transillumin
elisa
viru
neutralis
test
carri
serum
sampl
describ
pratelli
other
duplic
microtitr
plate
dickinson
labwar
serial
twofold
dilut
serum
sampl
start
mix
ccov
strain
infect
titr
plate
kept
room
temperatur
minut
freshli
trypsinis
cell
ad
well
plate
incub
five
day
viru
neutralis
antibodi
titr
express
reciproc
highest
serum
dilut
complet
inhibit
viral
cytopath
effect
antibodi
titr
lower
consid
neg
immunopl
nunc
roskild
coat
ccov
type
ii
antigen
strain
buonavoglia
other
dilut
carbon
buffer
per
cent
ph
incub
overnight
shake
plate
wash
salin
pb
buffer
contain
per
cent
tween
treat
block
solut
per
cent
gelatin
carbon
buffer
minut
wash
dog
serum
dilut
ad
duplic
plate
incub
minut
wash
cycl
goat
immunoglobulin
igg
sigma
chemic
dilut
ad
well
plate
incub
one
hour
anoth
wash
cycl
freshli
prepar
substrat
place
well
solut
consist
mg
sulfon
diammonium
salt
abt
sigma
chemic
phosphat
citrat
buffer
ph
contain
ml
hydrogen
peroxid
ad
stop
buffer
solut
per
cent
sodium
dodecyl
sulphat
optic
densiti
od
determin
nm
use
automat
elisa
reader
biorad
hercul
adjust
od
valu
sampl
obtain
subtract
absorb
mock
well
correspond
viru
well
sampl
od
valu
consid
posit
faecal
secretori
iga
antibodi
evalu
elisa
decaro
other
dog
vaccin
challeng
two
week
challeng
control
dog
briefli
immunopl
coat
ccov
antigen
dilut
carbon
buffer
treat
block
solut
faecal
sampl
dilut
ad
duplic
plate
incub
minut
wash
cycl
repeat
goat
iga
horseradish
peroxidas
conjug
bethyl
laboratori
ad
well
plate
incub
one
hour
wash
cycl
mg
freshli
prepar
substrat
abt
ad
od
nm
determin
valu
defin
od
less
viru
neutralis
titr
express
geometr
mean
od
valu
median
valu
two
dog
receiv
oronas
inocul
time
vaccin
dose
test
safeti
vaccin
local
system
reaction
wbc
count
remain
normal
throughout
observ
period
faecal
sampl
collect
day
dpv
consist
neg
viru
isol
pcr
assay
serolog
test
viru
neutralis
elisa
perform
dpv
indic
two
control
dog
develop
immun
respons
tabl
first
vaccin
faecal
sampl
collect
three
dog
use
efficaci
test
consist
neg
viru
isol
pcr
test
sera
collect
seven
dpfv
also
test
neg
viru
neutralis
elisa
sera
collect
dpfv
low
antibodi
titr
viru
neutralis
test
elisa
show
moder
reactiv
median
od
median
elisa
iga
od
valu
day
increas
dpfv
tabl
expect
ccov
detect
viru
isol
pcr
faec
dog
second
vaccin
entir
observ
period
dpsv
viru
neutralis
test
show
slight
increas
antibodi
titr
seven
dpsv
elisa
test
high
antibodi
valu
observ
seven
dpsv
median
od
dpsv
median
od
elisa
iga
median
od
valu
seven
dpsv
dpsv
tabl
challeng
field
strain
vaccin
dog
develop
clinic
sign
viru
isol
pcr
detect
viral
shed
neutralis
antibodi
vaccin
dog
increas
progress
approxim
geometr
mean
dpc
od
valu
elisa
test
also
increas
progress
reach
median
valu
dpc
median
elisa
iga
od
valu
seven
dpc
increas
dpc
tabl
two
control
dog
develop
mild
diarrhoea
averag
three
day
challeng
viru
isol
cell
cultur
faec
start
three
dpc
dog
two
dpc
dog
pcr
viru
detect
one
dpc
dog
dog
viru
neutralis
test
show
antibodi
increas
dpc
geometr
mean
serum
elisa
test
also
show
highest
od
valu
dpc
median
od
faecal
elisa
iga
median
od
dpc
tabl
ccov
discov
caus
agent
enter
dog
binn
other
import
pathogen
underestim
probabl
difficulti
identifi
viru
use
convent
virolog
assay
pratelli
other
reproduc
clinic
diseas
dog
experiment
condit
situat
caus
stress
dog
poor
nutrit
overcrowd
concurr
infect
pathogen
hypothesis
contribut
sever
ccov
diseas
field
case
evermann
other
yasoshima
other
pratelli
other
decaro
other
fulker
other
produc
clinic
diseas
dog
ccov
inocul
follow
treatment
immunosuppress
drug
dexamethason
studi
author
show
inactiv
ccov
vaccin
could
induc
immun
respons
protect
dog
clinic
sign
ccov
absenc
immunosuppress
caus
clinic
diseas
experiment
challeng
dog
monitor
reduct
viral
shed
use
test
efficaci
ccov
vaccin
recent
studi
found
inactiv
vaccin
poor
efficaci
reduc
faecal
shed
ccov
follow
infect
field
strain
viru
pratelli
other
subsequ
safeti
efficaci
ccov
vaccin
strain
evalu
dog
studi
show
advers
reaction
dog
inocul
vaccin
viral
nucleic
acid
detect
pcr
six
dpfv
dog
inocul
oronas
pratelli
other
aim
present
studi
develop
safe
immunogen
vaccin
would
result
viru
shed
purpos
ccov
vaccin
pratelli
other
attenu
passag
test
abil
immunis
dog
ccov
consid
poor
immunogen
dog
vaccin
twice
oronas
rout
interest
signific
immun
respons
observ
sera
faec
dog
second
inocul
challeng
dpsv
protect
ccov
infect
complet
viral
shed
observ
either
viru
isol
pcr
test
protect
ccov
infect
gener
associ
presenc
specif
antibodi
mucos
surfac
therefor
mucos
iga
vaccin
dog
tabl
might
respons
protect
observ
ogra
other
saif
decaro
other
although
ccov
infect
appear
major
caus
enter
dog
sever
ill
consequ
dual
infect
observ
evermann
other
yasoshima
other
pratelli
other
decaro
other
multipl
infect
common
popul
unvaccin
kennel
dog
may
shed
viru
long
six
month
clinic
sign
ceas
pratelli
other
seem
immunis
dog
produc
sterilis
immun
would
benefici
epidemiolog
effect
control
spread
ccov
dog
popul
epidemiolog
monitor
evolut
ccov
particularli
import
develop
ration
prophylaxi
exampl
document
recombin
event
affect
ccov
may
explain
evolutionari
process
lead
emerg
new
viru
strain
serotyp
subtyp
occur
new
genotyp
ccov
pratelli
other
new
pathogen
variant
ccov
isol
organ
dog
sever
lesion
buonavoglia
other
present
studi
shown
efficaci
ccov
vaccin
prevent
infect
dog
virul
viru
specif
abil
induc
sterilis
immun
